Skip to content

AcrySof™ IQ PanOptix™ UV IOL TFAT00 (REF TFAT00.100)Recalls & reported problems

Alcon Laboratories, Inc. · The AcrySof® IQ PanOptix® UV Absorbing Trifocal intraocular lenses (IOLs) are ultraviolet absorbing foldable multifocal IOLs · Class 3 · Implant

All models of AcrySof IQ PanOptix UV IOL (28)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380652429511), received between May 23, 2023 and Dec 12, 2024 — classified as 2 injuries.

The most frequently reported specific device problem is “Material Opacification” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 1 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Material Opacification1

Patient problems

  • Blurred Vision2
  • Dry Eye(s)1
  • Halo1
  • Irritability1
  • Visual Disturbances1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 12, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED BLURRED VISION. THE IOL WAS EXCHANGED FOR ANOTHER LENS 1 MONTH FOLLOWING THE INITIAL PROCEDURE. CLINICAL REASON FOR THE EXPLANT WAS MENTIONED AS MECHANICAL COMPLICATION.

    Patient problems: Blurred Vision

    MAUDE report 20914187 ↗
  • InjuryMay 23, 2023Material Opacification; Material Opacification

    A NON-HEALTH CARE PROFESSIONAL REPORTED FOLLOWING THE INTRAOCULAR LENS IMPLANTATION THE PATIENT HAD EXPRESSED SOME CONCERNS AND ISSUES ABOUT THE LENS THAT WAS IMPLANTED. THE PATIENT STATED MUST USE READERS, SINCE THE PATIENT CAN'T SEE UP CLOSE VERY GOOD, IT WAS LIKE THE LENS HAD A CLOUD OVER IT. THE PATIENT COULD SEE BETTER FROM THE LEFT EYE WITH A CONTACT LENS. IT SEEMS TO DO ALL OF THE WORK NOW. AT NIGHT, THERE IS A "HALO" OR "STARBURST" OF LIGHT WITH THE MULTI-FOCAL LENS TO WHERE THE PATIENT COULD NOT SEE OUT OF IT. THE PATIENT WAS CONSTANTLY USING EYE DROPS IN THE RIGHT EYE LIKE NEVER BEFORE, BECAUSE IT ALWAYS FEELS DRY AND IRRITATED, PRETTY MUCH EVERY DAY. SOMETIMES, IT'S LIKE THERE IS SOMETHING IN THE EYE, AS WHEN A CONTRACT LENS GETS CURLED UP IN THE TOP OF THE EYE BY ACCIDENT. IT IS VERY UNCOMFORTABLE MOST DAYS. THE PATIENT RECENTLY HAD THE YAG SURGERY ON RIGHT EYE REALLY DIDN'T NOTICE A DIFFERENCE AND STILL HAVE TO WEAR READERS TO SEE CLOSE UP. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Blurred Vision; Dry Eye(s); Halo; Irritability; Visual Disturbances

    MAUDE report 16982149 ↗

Other Lens, multifocal intraocular devices

All Lens, multifocal intraocular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page